Exact Sciences started rolling out its Cologuard Plus test in late March, after obtaining FDA approval and Medicare coverage, as a long-awaited update to its flagship home colorectal cancer screening ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Apax Partners has completed its acquisition of Exact for 730 million euros. Based in The Netherlands, Exact is a business software provider. LONDON–(BUSINESS WIRE)–Private equity group Apax Partners ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Exact Sciences announced on Wednesday that it acquired the rights to a blood-based ...

In an article published that morning and updated in the afternoon, Bloomberg reported that pharmaceutical sector mainstay Abbott Laboratories appears to be on the brink of acquiring Exact Sciences.

The two diagnostics companies estimate a combined market opportunity of about $20 billion for their breast, prostate and colorectal cancer assays—three areas that represent about 40% of solid tumor ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted ...